Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

EMA recommends discontinuation of lacosamide syrup

The European Medicines Agency (EMA) has recommended that lacosamide (Vimpat®) 15mg/ml syrup is discontinued. This product is licensed for the treatment of partial-onset seizures as an adjunctive therapy in patients with epilepsy aged 16 years and older.

This product was recalled voluntarily in September 2011 due to a quality issue that resulted in an uneven distribution or precipitation of the active ingredient. Changes to the storage recommendations of the product have not remedied this defect.

Patients are advised to continue taking their medication but to consult with their doctor. A license application for a 10mg/ml liquid product has been submitted. This product is not affected by this quality issue and is already available in the United States.

Clinicians should consider using lacosamide film coated tablets where appropriate. It may be possible to obtain the lower strength liquid product on a named patient basis where tablets will not be an option.

Action: Clinicians should be aware of this recommendation. The number of affected individuals should be small but changes to treatment will need careful planning.

Share 'EMA recommends discontinuation of lacosamide syrup' on Email Share 'EMA recommends discontinuation of lacosamide syrup' on Delicious Share 'EMA recommends discontinuation of lacosamide syrup' on Digg Share 'EMA recommends discontinuation of lacosamide syrup' on Facebook Share 'EMA recommends discontinuation of lacosamide syrup' on Google+ Share 'EMA recommends discontinuation of lacosamide syrup' on reddit Share 'EMA recommends discontinuation of lacosamide syrup' on StumbleUpon Share 'EMA recommends discontinuation of lacosamide syrup' on Twitter

atomic-wealth

No Comments to “EMA recommends discontinuation of lacosamide syrup”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,208 spam comments.

atomic-wealth
fond-illness
summer